Biologic hernia repair mesh market seen reaching $2.63 billion by 2030

The Business Research Company projects the biologic hernia repair mesh market will grow from $1.85 billion in 2025 to $2.63 billion by 2030, driven by more hernia cases, greater use of regenerative materials and demand for infection-resistant repair options. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The biologic hernia repair mesh market is expanding as surgeons look for repair options that can support healing in infection-prone or complex cases. - Rising demand matters because hernia surgeries are increasing alongside obesity and other factors that raise the risk of abdominal wall weakness. - Market growth also signals more use of regenerative, absorbable materials in operating rooms and ambulatory surgical centers.

What happened: - The Business Research Company released a study on the biologic hernia repair mesh market on July 29, 2026. - The report estimates the market will rise from $1.85 billion in 2025 to $1.99 billion in 2026. - The study projects the market will reach $2.63 billion by 2030. - The forecast implies a 7.6% CAGR from 2025 to 2026 and a 7.2% CAGR through 2030.

The details: - Biologic hernia repair mesh is made from processed human or animal tissue and is designed to reinforce weakened tissue during hernia surgery. - The mesh is gradually absorbed by the body and supports natural tissue regeneration. - The report links near-term growth to more hernia cases, limits of synthetic mesh in infection-prone settings, higher surgical volumes, more hospital-based repairs and early adoption of tissue-based implants. - Long-term growth is tied to advances in biologic tissue processing, demand for customized repair solutions, greater awareness of post-surgical complications, growth in ambulatory surgical centers and more surgeon preference for regenerative materials. - Key trends include more use in high-risk repairs, broader acceptance of absorbable and regenerative mesh, expansion into complex and contaminated surgeries, wider adoption of minimally invasive and laparoscopic procedures, and a stronger clinical focus on reducing infection and recurrence. - The report says the market covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report also highlights market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies and future trends, plus updated graphics and tables. - The Business Research Company offers a free sample report and the full market report through its website, with links to the sample report and the full report.

Between the lines: - The forecast suggests biologic mesh is moving from a niche option toward a broader role in complicated hernia repairs. - The strong regional split points to a mature North American market and faster adoption potential in Asia-Pacific. - The registry example in the release shows how clinical tracking of hernia cases is becoming more formalized, which can support ongoing demand for repair materials. - The British Hernia Society Registry launched in November 2024 and had more than 100 surgeons registered at its inaugural conference. - By January 2025, the registry had logged 400 cases from 30 surgeons across 31 hospitals.

What's next: - The market is expected to keep growing as biologic tissue processing improves and surgeons increase use in high-risk and minimally invasive procedures. - Adoption will likely track demand for treatments that reduce infection and recurrence in complex hernia cases. - Regional growth will likely remain strongest in Asia-Pacific if current forecast trends hold. - The Business Research Company lists Saumya Sahay as a contact for expert inquiries.